This is the sixth successful USFDA inspection completed by the company. Ind- Swift Supplies 15 APIs (Active Pharmaceutical Ingredients) to its customers based in the US. The APIs manufactured from the Derabassi facility are supplied to over 70 countries covering more than 280 customers including all the major drug manufacturers across the Globe, the company said in a statement.

Ind-Swift Laboratories manufactures bulk drugs and intermediates. The company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.